文献速递妇科

平价医疗法案与卵巢癌诊疗的关联

Association of the Affordable Care Act With Ovarian Cancer Care.
PubMed 文献 · Obstet Gynecol · 2020-01-01

该回顾性队列研究采用双重差分分析,比较2010年ACA实施前后21-64岁与65岁以上卵巢癌患者在诊断分期和治疗时间上的变化。结果显示ACA与早期诊断率提高1.4%(95%CI 0.4-2.4)及30天内治疗率提高2.3%(95%CI 1.7-3.0)相关。

要点

  • ACA实施与卵巢癌早期诊断率提高1.4%相关(95%CI 0.4-2.4)。
  • ACA实施与30天内接受治疗率提高2.3%相关(95%CI 1.7-3.0)。
  • 公共保险人群早期诊断和治疗及时性改善更显著。

核心结论

  • ACA实施与卵巢癌更早分期诊断及诊断后30天内治疗相关。

研究设计与样本

  • 回顾性队列研究,采用双重差分分析,暴露组为21-64岁卵巢癌患者,对照组为65岁及以上患者。
  • 使用2004-2015年美国国家癌症数据库数据,暴露组改革前39,999例、改革后36,564例,对照组改革前31,290例、改革后29,807例。
  • 分析调整了城乡、收入与教育水平、合并症、就医距离、地区及学术中心诊疗等因素。

主要发现

  • ACA与21-64岁女性相比65岁及以上女性早期诊断率提高1.4%(95%CI 0.4-2.4)相关。
  • ACA与更多女性在卵巢癌诊断后30天内接受治疗相关(2.3%,95%CI 1.7-3.0)。
  • 公共保险女性中,ACA与早期诊断改善(2.7%,95%CI 1.0-4.5)及30天内治疗改善(2.5%,95%CI 1.2-3.8)相关。
  • 治疗时间改善在不同种族和收入组中均可见。

临床怎么用

  • 关注ACA相关保险覆盖对卵巢癌早期诊断和及时治疗的潜在促进作用。
  • 在临床实践中重视诊断后30天内启动治疗的时间窗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate how implementation of the 2010 Affordable Care Act (ACA) might be associated with stage at diagnosis and time to treatment for women with ovarian cancer. METHODS: We conducted a retrospective cohort study using difference-in-differences analysis comparing stage at diagnosis and time to treatment before and after implementation of the ACA among women with ovarian cancer aged 21-64 years (exposure group) compared with women aged 65 years or older (control group). Using 2004-2015 data from the National Cancer Database, outcomes were analyzed overall and by insurance type and race, adjusting for urban-rural, income and education level, comorbidities, distance traveled for care, region, and care at an academic center. RESULTS: A total of 39,999 ovarian cancer cases prereform and 36,564 postreform were identified for women aged 21-64 years compared with 31,290 cases prereform and 29,807 postreform for women aged 65 years or older. The ACA was associated with increased early-stage diagnosis detection for women aged 21-64 years compared with women 65 and older (difference-in-differences 1.4%, 95% CI 0.4-2.4). The ACA was associated with more women receiving treatment within 30 days of ovarian cancer diagnosis (2.3%, 95% CI 1.7-3.0). Among women with public insurance, the ACA was associated with a significant improvement in early-stage diagnosis and receipt of treatment within 30 days of diagnosis (difference-in-differences 2.7%, 95% CI 1.0-4.5, difference-in-differences 2.5%, 95% CI 1.2-3.8). Improvements in time to treatment were seen across race and income groups. CONCLUSION: Implementation of the ACA was associated with earlier ovarian cancer stage at detection and treatment within 30 days of diagnosis.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Smith AJB, Fader AN. Association of the Affordable Care Act With Ovarian Cancer Care. Obstet Gynecol. 2020. PMID: 31923060. doi:10.1097/AOG.0000000000003630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。